Hormone Replacement Therapy in Houston: A Complete Patient Guide

Hormone replacement therapy is one of the most asked about and least clearly explained categories of medicine. For women navigating perimenopause and menopause, for men dealing with low testosterone, and for patients of any age noticing the symptoms of hormonal decline, the question of whether to pursue HRT  and how to do it well comes up regularly. The information available online is uneven. Clinics in Houston range from genuinely thorough to transactional. Patient confusion is the rule, not the exception.

This guide is a comprehensive overview of hormone replacement therapy as it is practiced today: what HRT actually is, who it is for, what the modern evidence shows, the major delivery methods, what monitoring should look like, and how Houston patients should think about evaluating their options. We have written it as the resource we wish more patients had access to before their first consultation — at our clinic or anywhere else.

What hormone replacement therapy is

Hormone replacement therapy is the use of medication to address a hormone deficiency or imbalance. In clinical practice, the term most often refers to two distinct populations: women navigating the hormonal changes of perimenopause and menopause, and men dealing with low testosterone — most commonly the gradual decline of male hormones with age (sometimes called andropause).

The clinical principle is straightforward. If your body is no longer making enough of a particular hormone, and the symptoms or health risks of that deficiency are meaningful, therapy can restore those hormones to levels that support symptom management, function, and long-term health. The mechanism is direct — unlike many peptides, which signal pathways to do something, hormone replacement supplies the hormone itself.

This is well-established medicine with decades of clinical evidence. The therapies have evolved substantially since their early forms in the mid-20th century. The molecules are better, the delivery methods are more precise, the monitoring is more rigorous, and the safety profile is better understood than at any point in the field’s history.

The Tide offers HRT across both populations. Our men’s hormone health service covers testosterone replacement therapy and related male hormone optimization. Our women’s hormone health service covers estrogen, progesterone, and testosterone for women across perimenopause, menopause, and beyond.

Who hormone replacement therapy is for

HRT is appropriate when bloodwork demonstrates a hormone deficiency and your symptoms are consistent with that deficiency. That framing matters — neither symptoms alone nor labs alone determine whether someone is a candidate. Both are evaluated together, alongside medical history, family history, current medications, and other clinical considerations.

For women, hormone replacement most commonly addresses the symptoms of perimenopause and menopause. The transition typically begins in the early-to-mid 40s, sometimes earlier, and extends through the final menstrual period and the years that follow. The symptoms are broad: hot flashes and night sweats, sleep disruption, mood changes, brain fog, vaginal dryness and sexual discomfort, joint pain, declining bone density, changes in body composition, and others. Not every woman experiences every symptom, and severity varies enormously. The clinical question is not “is she menopausal” — almost every woman over a certain age is or will be — it is “are her symptoms and risk factors significant enough to warrant therapy.”

For men, the equivalent question is whether testosterone has declined to a level that is producing symptoms — fatigue, low libido, reduced erectile function, loss of muscle mass and strength, mood changes, brain fog, weight gain, sleep changes. Total and free testosterone are evaluated on accurate morning bloodwork (timing matters because levels vary across the day), and the combination of lab values and symptoms determines whether testosterone replacement therapy is appropriate.

There are also women who benefit from testosterone — usually small physiologic doses, distinct from male TRT — for libido, energy, and body composition in perimenopause and beyond. This use is less commonly discussed but is increasingly supported by the literature and is part of comprehensive women’s hormone health.

The modern evidence base

The conversation about HRT in the United States has been shaped, perhaps more than any other factor, by the Women’s Health Initiative (WHI) study results published in 2002. The initial reporting suggested HRT increased risks of breast cancer, cardiovascular disease, and other adverse outcomes. The reaction was sweeping — prescriptions plummeted, clinics stopped offering HRT, and a generation of women avoided therapy that would have substantially improved their lives.

The story since 2002 has been a gradual correction. Reanalysis of the WHI data, additional studies, and improved understanding of how hormone type, dose, route of administration, and patient age affect outcomes have substantially changed the clinical picture. Modern evidence supports that for women starting HRT within roughly ten years of their final menstrual period — sometimes called the “timing hypothesis” — the benefit-risk balance is generally favorable, particularly when bioidentical hormones are used and delivery routes are optimized.

The same arc has played out for men’s testosterone replacement, though with less public drama. Concerns about cardiovascular risk and prostate cancer that drove caution in earlier decades have been substantially refined by better-quality research. Modern TRT, when prescribed appropriately and monitored carefully, has a favorable safety profile in patients without specific contraindications.

What this means in practice: the older narrative that HRT is universally dangerous is outdated. The newer narrative — that HRT is universally safe and beneficial — is also incomplete. The actual picture is more nuanced. HRT is appropriate for many patients, contraindicated for some, and requires individualized clinical judgment in nearly every case. A clinic that gives you a one-line answer in either direction is oversimplifying.

Delivery methods: how hormones are administered

One of the most underappreciated aspects of HRT is that the delivery method matters significantly — for both the safety profile and the patient experience.

Transdermal patches and gels deliver hormones through the skin into the bloodstream, bypassing the liver. This route is generally preferred for estrogen because it has a more favorable cardiovascular and clotting risk profile than oral estrogen. Patches and gels provide steady-state hormone levels and are easy to titrate.

Oral preparations are still used, particularly for progesterone (which is often given orally for sleep and uterine protection in women on estrogen) and for testosterone replacement in men through specific oral formulations. Oral estrogen, while still prescribed, is less favored in modern practice for the reasons mentioned above.

Injections are the most common delivery method for testosterone replacement in men, typically administered weekly or twice weekly. They provide reliable absorption, predictable dosing, and the flexibility to adjust frequency and amount based on labs and response. Injections can also be used for some forms of estrogen in specific clinical situations.

Hormone pellets are small bioidentical hormone implants placed under the skin, typically in the hip area, that release hormones steadily over three to six months. Pellets are popular because they eliminate daily dosing and provide consistent levels, but they are not the right delivery method for every patient. Pellets cannot be easily removed if a dose adjustment is needed, and the steady-state release is sometimes too aggressive for patients who would do better with gradual titration.

Creams and topical preparations are useful for specific applications — localized estrogen cream for vaginal symptoms, for example — and as part of comprehensive protocols that combine systemic and local therapy.

Our bioidentical hormone replacement protocols evaluate which delivery method fits each patient based on their goals, lifestyle, medical history, and response to prior therapy. The right method for one patient is not necessarily the right method for another.

The bioidentical question

The distinction between bioidentical and synthetic hormones is one of the most discussed topics in HRT, and one of the most often misunderstood.

Bioidentical hormones are molecularly identical to the hormones the human body produces — estradiol, progesterone, and testosterone in their natural chemical structure. They can be manufactured by pharmaceutical companies (FDA-approved bioidentical products exist for several hormones) or by compounding pharmacies (which produce bioidentical formulations in custom doses and combinations).

Synthetic hormones, in this context, refer to molecules that are structurally different from human hormones but produce similar biological effects. Conjugated equine estrogens (CEE) and synthetic progestins like medroxyprogesterone acetate are examples. These have been used for decades and are still appropriate for some patients, but the bioidentical alternatives are generally preferred in modern practice for several reasons — metabolic profile, side effect tolerance, and patient preference among them.

At The Tide, we default to FDA-approved bioidenticals where they are available and clinically appropriate, and use compounded bioidentical preparations when the specific patient needs a formulation, dose, or combination that FDA-approved products cannot provide. Both are bioidentical. Both are clinically valid. The choice between them depends on the clinical situation, not on marketing terminology.

What clinical monitoring should look like

HRT done well is not “set and forget.” It is an ongoing clinical relationship with regular monitoring, dose adjustments based on response, and periodic reassessment of whether the protocol is still serving the patient’s needs.

Baseline labs are the starting point. For women, this typically includes a comprehensive hormone panel (FSH, LH, estradiol, progesterone, testosterone, DHEA-S, thyroid panel, sex hormone binding globulin), a metabolic panel, lipid panel, complete blood count, and additional markers as indicated by the medical history. For men, the baseline includes a comprehensive hormone panel (total and free testosterone, estradiol, LH, FSH, prolactin, SHBG, PSA in age-appropriate patients, thyroid panel), metabolic and lipid panels, complete blood count with hematocrit (which matters specifically for TRT monitoring), and other relevant markers.

Follow-up labs are typically run at 6-8 weeks after starting therapy or after a dose change, then quarterly for the first year, then every six months once a patient is stable on a given protocol. The specific timing depends on the therapy, the delivery method, and how the patient is responding.

Clinical follow-up matters as much as labs. Hormone replacement is fundamentally about symptom management and quality of life, and lab values alone don’t tell that story. Patient-reported outcomes — sleep quality, energy, mood, libido, physical function, cognitive clarity, and others — are essential parts of evaluating whether a protocol is working. Our advanced labs service integrates biomarker tracking with clinical follow-up so that the protocol can be refined based on the full picture.

HRT and peptide therapy together

HRT and peptide therapy are sometimes presented as alternatives. They are not — they are complementary categories of medicine that address different clinical problems and frequently benefit the same patients.

A man on testosterone replacement may also benefit from a growth hormone-supporting peptide like sermorelin if his recovery, body composition, or sleep architecture is not fully addressed by testosterone alone. A woman on estrogen and progesterone replacement may benefit from a metabolic peptide if she is also dealing with significant insulin resistance or weight management challenges. A patient on either protocol may benefit from regenerative peptides like BPC-157 if they have specific recovery or tissue repair needs.

The clinical structure for combining the two is to address the hormone deficiency first when one is present, allow the patient to stabilize on hormone optimization, and then evaluate whether peptide therapy adds value to the specific remaining clinical concerns. This sequencing matters — peptides do not substitute for hormones when hormones are what’s actually needed, and starting both simultaneously can make it harder to attribute response to either intervention.

What Houston patients should ask before starting HRT

Several questions distinguish a thorough hormone clinic from a transactional one:

What labs are you running before prescribing? If the answer is minimal — just total testosterone for men, or just FSH for women — you are not getting the comprehensive evaluation that good HRT requires. A proper baseline includes hormone panel, metabolic markers, and other indicators of overall health that inform protocol design.

How do you decide between delivery methods? If the clinic only offers one delivery method, that is a limitation. Different delivery methods suit different patients, and the choice should be based on your clinical picture, not on what the clinic happens to stock.

What is your monitoring schedule? A thorough clinic re-checks labs at 6-8 weeks after starting or after a dose change, then quarterly for the first year. A clinic that prescribes and only sees you again at refill time is not providing clinical care.

How do you adjust protocols over time? Hormones change. Bodies change. The first protocol is rarely the one a patient stays on indefinitely. A thorough clinic adjusts based on labs, response, and changing goals.

What is your approach to bioidentical vs synthetic hormones? Most modern clinics default to bioidenticals for good reasons. A clinic that exclusively uses synthetic preparations or that cannot articulate why they use what they use is operating with outdated tools.

What are the contraindications you screen for? Personal and family history of hormone-sensitive cancers, clotting disorders, cardiovascular disease, and other conditions affect whether HRT is appropriate. A clinic that doesn’t ask is missing important safety information.

HRT and the Houston medical landscape

Houston has a complicated HRT landscape. The Texas Medical Center anchors world-class endocrinology and OB-GYN care. Surrounding the TMC are dozens of clinics offering various forms of hormone therapy — some excellent, some adequate, some primarily transactional. The Houston metro area has more hormone therapy options per capita than many comparable cities, but quality varies widely.

For Houston patients, the practical implication is that you have options. You do not need to settle for a clinic that doesn’t run comprehensive labs, doesn’t offer multiple delivery methods, or doesn’t provide structured follow-up. Geography is not a constraint here the way it might be in smaller markets.

The Tide is one of those options. We are located adjacent to the Texas Medical Center, and our approach to hormone replacement is designed around the same principles that govern our peptide therapy work — comprehensive evaluation, individualized protocols, multiple delivery methods, ongoing monitoring, and honest discussion of risks and benefits. We treat hormone replacement as serious clinical medicine that deserves the structure of serious clinical medicine.

How to think about whether HRT is right for you

If you are experiencing the symptoms that hormone replacement addresses — and they are affecting your quality of life — the question is whether the underlying cause is hormonal and whether replacement is the right tool to address it. That answer requires labs and a clinical conversation. It is not a decision you should make based on a website article, including this one.

The patients who do best with hormone replacement therapy tend to share a few traits. They have specific symptoms they want addressed. They are willing to do the work that good clinical care requires — labs, follow-up appointments, adjustments over time. They want to understand what they are taking and why. They have realistic expectations about what hormones can and cannot do.

The patients who tend to be disappointed are those who expected hormones to fix everything, who started therapy without adequate evaluation, or whose protocol was templated rather than individualized. In most of those cases, the disappointment was not the fault of the hormones themselves. It was the structure around them.

If you are in Houston and considering hormone replacement therapy, the right next step is a comprehensive consultation with a clinician who specializes in this work — someone who will take the time to understand the goal, evaluate your medical context, run appropriate baseline labs, design an individualized protocol, and follow up to see whether it is working.

About The Tide

The Tide is a peptide-focused medical clinic in Houston, Texas, located adjacent to the Texas Medical Center. We offer comprehensive hormone replacement therapy through our men’s hormone health and women’s hormone health services, prescribing testosterone replacement therapy, estrogen and progesterone replacement, bioidentical hormones, and hormone pellets based on individual clinical needs. Every patient begins with comprehensive baseline labs and a 45-minute physician consultation. For deeper reading on how we approach our work, see our clinical standards and programs.